Alcohol Consumption Among HIV-Infected Women: Impact on Time to Antiretroviral Therapy and Survival

被引:51
|
作者
Neblett, Robyn C. [1 ]
Hutton, Heidi E. [2 ]
Lau, Bryan [3 ]
McCaul, Mary E. [2 ]
Moore, Richard D. [1 ]
Chander, Geetanjali [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
IDENTIFICATION TEST AUDIT; UNITED-STATES; TEMPORAL RELATIONSHIP; GENDER-DIFFERENCES; HEPATITIS-C; ADHERENCE; MORTALITY; COHORT; NONADHERENCE; PREDICTORS;
D O I
10.1089/jwh.2010.2043
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Alcohol use is prevalent among HIV-infected people and is associated with lower antiretroviral adherence and high-risk sexual and injection behaviors. We sought to determine factors associated with alcohol use among HIV-infected women engaged in clinical care and if baseline alcohol use was associated with time to combination antiretroviral therapy (cART) and death in this population. Methods: In an observational clinical cohort, alcohol consumption at the initial medical visit was examined and categorized as heavy, occasional, past, or no use. We used multinomial logistic regression to test preselected covariates and their association with baseline alcohol consumption. We then examined the association between alcohol use and time to cART and time to death using Kaplan-Meier statistics and Cox proportional hazards regression. Results: Between 1997 and 2006, 1030 HIV-infected women enrolled in the cohort. Assessment of alcohol use revealed occasional and hazardous consumption in 29% and 17% of the cohort, respectively; 13% were past drinkers. In multivariate regression, heavy drinkers were more likely to be infected with hepatitis C than nondrinkers (relative risk ratios [RRR] 2.06, 95% confidence interval [CI] 1.29-3.44) and endorse current drug (RRR 3.51, 95% CI 2.09-5.91) and tobacco use (RRR 3.85 95% CI 1.81-8.19). Multivariable Cox regression adjusting for all clinical covariates demonstrated an increased mortality risk (hazard ratio [HR] 1.40, 95% CI 1.00-1.97, p < 0.05) among heavy drinkers compared to nondrinkers but no delays in cART initiation (1.04 95% CI 0.81-1.34) Conclusions: Among this cohort of HIV-infected women, heavy alcohol consumption was independently associated with earlier death. Baseline factors associated with heavy alcohol use included tobacco use, hepatitis C, and illicit drug use. Alcohol is a modifiable risk factor for adverse HIV-related outcomes. Providers should consistently screen for alcohol consumption and refer HIV-infected women with heavy alcohol use for treatment.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 50 条
  • [1] Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems
    Samet, JH
    Horton, NJ
    Meli, S
    Freedberg, KA
    Palepu, A
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (04) : 572 - 577
  • [2] Hormonal contraception and antiretroviral therapy among HIV-infected women
    Amaral, Eliana
    Martino Viscola, Marco Aurelio
    Bahamondes, Luis
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2006, 28 (11): : 680 - 684
  • [3] Antiretroviral therapy for pregnant HIV-infected women
    Luber, AD
    Dong, BJ
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 509 - 509
  • [4] The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States
    Zhang, Yuehan
    Wilson, Tracey E.
    Adedimeji, Adebola
    Merenstein, Daniel
    Milam, Joel
    Cohen, Jennifer
    Cohen, Mardge
    Golub, Elizabeth T.
    [J]. AIDS AND BEHAVIOR, 2018, 22 (03) : 896 - 908
  • [5] The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States
    Yuehan Zhang
    Tracey E. Wilson
    Adebola Adedimeji
    Daniel Merenstein
    Joel Milam
    Jennifer Cohen
    Mardge Cohen
    Elizabeth T. Golub
    [J]. AIDS and Behavior, 2018, 22 : 896 - 908
  • [6] Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
    Hogg, RS
    Heath, KV
    Yip, B
    Craib, KJP
    O'Shaughnessy, MV
    Schechter, MT
    Montaner, JSG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 450 - 454
  • [7] Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients
    de Olalla, PG
    Knobel, H
    Carmona, A
    Guelar, A
    López-Colomés, JL
    Caylà, JA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (01): : 105 - 110
  • [8] Antiretroviral therapy and preterm birth in HIV-infected women
    Short, Charlotte-Eve S.
    Taylor, Graham P.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (03) : 293 - 306
  • [9] Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility
    Mostashari, F
    Riley, E
    Selwyn, PA
    Altice, FL
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 (04): : 341 - 348
  • [10] IMPACT OF TUBERCULOSIS ON MORTALITY AMONG HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
    Chu, R.
    Mills, E.
    Beyene, J.
    Bakanda, C.
    Nachega, J.
    Thabane, L.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S73 - S73